X0303 4 2011-01-31 0 0001047699 KING PHARMACEUTICALS INC KG 0001206367 GREETHAM ELIZABETH M 13 HARBOUR DRIVE HAMILTON PARISH D0 HS02 BERMUDA 1 0 0 0 Common Stock 2011-01-31 4 U 0 12794 D 0 D Restricted Stock Units 2011-01-31 4 D 0 28885 D Common Stock 28885 0 D Restricted Stock Units 2011-01-31 4 D 0 16201 D Common Stock 16201 0 D Stock Option (Right to Buy) 8.00 2011-01-31 4 J 0 10000 D 2015-04-29 Common Stock 10000 0 D The reported transaction represents shares of common stock tendered to Parker Tennessee Corp. ("Acquisition Sub"), a wholly-owned subsidiary of Pfizer Inc. ("Pfizer"), pursuant to Acquisition Sub's offer to purchase all of the issued and outstanding shares of common stock, no par value per share, of King Pharmaceuticals, Inc. ("King") at a price of $14.25 per share, net to the seller in cash, without interest and less any required withholding taxes, upon the terms and conditions described in the Tender Offer Statement on Schedule TO filed with the SEC by Pfizer and Acquisition Sub on October 22, 2010, as amended (the "Tender Offer"). Each Restricted Stock Unit ("RSU") represents a right to receive one share of common stock of King. Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2010, among Pfizer, King and Acquisition Sub (the "Merger Agreement"), these RSUs, whether or not vested, were fully vested immediately prior to and canceled immediately following Acquisition Sub's acceptance of the common stock tendered and not validly withdrawn in accordance with the Tender Offer Statement on Schedule TO filed with the SEC by Pfizer and Acquisition Sub on October 22, 2010, as amended (the "Acceptance Time") in exchange for the right to receive cash payment for each RSU of $14.25, net to the seller in cash, without interest and less any required withholding taxes. Pursuant to the Merger Agreement, these RSUs, whether or not vested, were fully vested immediately prior to and canceled immediately following the Acceptance Time in exchange for the right to receive cash payment for each such RSU of $14.25, net to the seller in cash, without interest and less any required withholding taxes. Pursuant to the Merger Agreement, these stock options, whether or not vested, were fully vested immediately prior to and canceled immediately following the Acceptance Time in exchange for the right to receive cash payment for each such option of the excess of $14.25 per option, net to the seller in cash, without interest and less any required withholding taxes, over the per-share exercise price of such option. /s/ Elizabeth M. Greetham 2011-02-02